Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature Adenoid cystic carcinoma (ACC) is a relatively rare slow-growing and often-aggressive epithelial-myoepithelial neoplasm that arises in multiple organs including the skin. The t(6;9) (q22-23;p23-24) translocation, resulting in a MYB-NFIB gene fusion has been found in ACCs from the salivary glands and other organs. Recently, MYB aberrations occurring in a subset (40%) of primary cutaneous ACC (PCACC) examples was described. Herein, we report three additional cases of PCACC harboring MYB aberrations. The tumors presented in three males aged 43, 81 and 55 years old and affected the extremities in the first two patients and the scalp in the third one. None of the patients had history of prior or concurrent ACC elsewhere. Lesions exhibited the classic ACC morphology of nests of basaloid cells arranged in cribriform and adenoid patterns. Sentinel lymph node biopsy was performed in two cases with one case showing lymph node positivity. Fluorescence in situ hybridization with break-apart probes for MYB and NFIB loci revealed that two cases showed MYB rearrangements while one case showed loss of one MYB signal. None of the cases showed NFIB rearrangements. We contribute with three additional cases of PCACC exhibiting MYB aberrations, the apparent driving genetic abnormality in these tumors.
patterns: cribriform, solid and tubular. 1 Primary cutaneous ACC (PCACC) is a rare occurrence. After excluding ACCs originating in the periocular and ear canal regions, few reports and small series of PCACC cases can be found with an overall count of 114 cases documented to date in the English literature. This list includes the first report by Boggio, 2 as well as three tumors that predate that publication and were reported under different rubrics 3 -5 and were later retrospectively deemed to be PCACCs. 6 An epidemiologic study utilizing data from the United States Surveillance, Epidemiology and End Results (SEER) program indicated that 152 cases of PCACC were diagnosed (not necessarily published) in the 30-year period spanning from 1976 to 2005, yielding an incidence rate of 0.23 cases per 1 million people per year. 7 This SEER-based study also pointed out that PCACC arises in older patients with a median age of 64 years (mean: 63 years, range: 23-94 years), has a predilection for the head and neck/face region and a low-grade yet protracted clinical course including multiple recurrences. 7 Although very useful and important, SEER-based studies could be afflicted by potential 'contamination' from misdiagnosed cases, as the actual pathology of the cases is usually not reviewed.
Although ACCs are overall easy to recognize, overlap with other entities exists. In the particular case of PCACC the following entities should be included in the differential diagnosis: basal cell carcinoma (BCC) with prominent adenoid features 8 and the rare adnexal tumors apocrine cribriform carcinoma (ACrC) 9 and polymorphous sweat gland carcinoma (PSGC). 10 Occasionally, PCACC tumors will be difficult to distinguish from other basaloid adnexal tumors such as cylindroma and spiradenoma, particularly if some overlapping features are present. 1 Following the description of the t(6;9) (q22-23;p23-24) MYB-NFIB translocation in head and neck and breast ACCs, 11 -13 subsequent studies showed that this aberration was also found in ACCs arising from other anatomical locations including the skin. 14 Herein, we present our findings from three additional PCACC tumors that include analysis of MYB and NFIB aberrations by fluorescence in situ hybridization (FISH) studies as well as follow-up clinical information. In addition, given the rarity of PCACC, we underwent an extensive review of the English literature on this particular subject.
Materials and methods
A total of three PCACC cases were captured from the archives of Baystate Medical Center (BMC) (cases 1 and 2) and Moffitt Cancer Center (MCC) (case 3) Pathology Departments. Available clinicopathologic information, including clinical pictures and follow-up information, were reviewed. Importantly, the possibility of a cutaneous metastasis from a potential primary ACC tumor arising in a different anatomical location (head and neck, lung, breast, etc.) was completely ruled out in all patients. The hematoxylin and eosin histomorphologic features of the tumors were rereviewed in all three cases. FISH studies on interphase nuclei were performed at Memorial Sloan Kettering Cancer Center (MSKCC) using a two-color custom bacterial artificial chromosomes break-apart probe mix directed toward regions flanking the MYB and NFIB loci (red: centromeric; green: telomeric). This probe mix was applied on formalin-fixed paraffin-embedded 4-μm thick unstained sections and successive nuclei (200) were examined using a Zeiss fluorescence microscope (Zeiss Axioplan, Oberkochen, Germany), controlled by Isis 5 software (Metasystems, Newton, MA, USA).
A review of the literature on PCACC was performed. A PubMed search using 'primary cutaneous adenoid cystic carcinoma' was carried out and all publications on the subject that were available in English up to the date of this manuscript's preparation (July to August 2016) were reviewed. Several epidemiologic and clinicopathologic parameters were recorded, if available.
In order to specifically study the primary cutaneous cases, we excluded ACC cases arising from the periocular and outer ear glandular systems as well as cases that had originated in anatomical areas in which a primary ACC from other organs would be impossible to rule out (e.g. 'parotid region').
Results

Case 1
The first tumor arose in a 43-year-old male as a slow-growing, non-tender 7-cm right forearm mass that developed in a 10-year period (Fig. 1A) . The lesion was excised and appeared grossly as a well-circumscribed mass with homogeneous grey-tan cut surfaces exhibiting tiny cystic spaces ( Fig. 2A) . Microscopic examination revealed a basaloid tumor exhibiting the classic morphologic picture with an ACC with a predominant cribriform growth pattern (Fig. 2B) . Two cell types formed the neoplasm: basaloid and myoepithelial (Fig. 2C ). The cells formed numerous cystic spaces that were lined by Periodic Acid Schiff (PAS) positive basal membrane material (not shown). No perineural invasion (PNI) was noted. Break-apart probe FISH analysis for the MYB locus revealed a balanced rearrangement with the MYB split present in the majority of the cells (Fig. 3A, arrows) , the NFIB region was not rearranged (not shown).
The tumor was present at the deep margin in the initial excision and two subsequent reexcisions were performed which were negative for residual component. The area was postoperatively irradiated. Although the patient was deemed to be free of disease following surgery and radiotherapy, the tumor locally recurred approximately 60 months after the diagnosis, exhibiting identical morphologic features to the original tumor (no higher grade progression).
Case 2
The second case occurred in an 81-year-old male with history of gastric diffuse large B-cell lymphoma status post Rituximab with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R_CHOP) chemotherapy that presented with a right tibial cutaneous nodule of several years in duration that became increasingly tender. Upon excision, the tumor proved to be a highly infiltrative neoplasm invading to a depth of 10 mm that was composed of basaloid and myoepithelial cells disposed in a predominantly tubular and focally cribriform array (Fig. 2D) . Bluish mucinous/myxoid material was found both in the stroma and within cystic spaces (Fig. 2E ). There was PNI (not shown) and the tumor was present at the deep margin. Upon FISH analysis, this tumor revealed a balanced MYB split and a preserved NFIB (not shown).
A sentinel lymph node biopsy was performed and yielded one of two inguinal lymph nodes (1/2) being positive for metastatic disease (Fig. 2F, arrowheads) , and the subsequent completion dissection showed seven negative lymph nodes (0/7). Three subsequent reexcisions with skin grafting were necessary to obtain clear margins and adjuvant radiotherapy of the area was carried out. The patient remains free of disease 48 months following the diagnosis.
Case 3
A 55-year-old male complaining of a tender subcutaneous indurated lesion on the left scalp (Fig. 1B) represents the third and final case. An excision showed a tumor composed of infiltrating basaloid cells that were arranged in tubular and cribriform patterns, which were deeply invasive into the subcutaneous adipose tissue ( Fig. 2G-I ). The lesion invaded to a depth of 8 mm and measured 7 mm in width. Multifocal PNI (Fig. 2H , arrows) was seen and the tumor involved the deep margin. FISH studies for MYB and NFIB showed that, in contrast to the first two cases, this particular tumor exhibited three copies of MYB per cell with a subset of tumor cells showing deletions of the centromeric (3 ′ portion) of the MYB locus (Fig. 3B, arrows) .
A sentinel lymph node biopsy procedure was performed, yielding one negative right cervical lymph node (0/1). Radiotherapy was administered and a subsequent reexcision revealed no evidence of residual tumor. The patient was found to be disease-free after 7 months of the surgery.
Review of the literature
The PubMed-based search revealed a total of 114 PCACC published cases the majority of which were part of case reports, 1 -7,9,15-60 with only a couple of small series 61, 62 and four relatively large series first authored by Seab & Graham, 63 Urso et al., 64 Ramakrishnan et al. 65 and North et al., 14 which included 10, 5, 27 and 19 PCACC cases, respectively. After including our three cases, complete clinical information was found in 116 cases with 1 case that was reported as part of an immunohistochemical study did not include any clinical data. 56 PCACC tumors had a tendency to affect older individuals with the median age being 60 years old (mean: 62; range: 14-92), while the gender distribution was almost equal among males (n = 59) and females (n = 57). Regarding anatomical location, almost half of the lesions (n = 53, 46%) arose in the head and neck region; particularly in the scalp (n = 40, 34% of total cases), followed by the thoracic region (n = 15, 13%). Tumors arose less frequently in the abdomen (n = 13, 11%), upper (n = 11, 10%) and lower (n = 10, 8%) limbs. Similarly, the back (n = 8, 7%) and the genitalia/perineal area (n = 6, 5%) were also infrequently involved. Tumors developed over long periods of time, usually decades, with the median time to diagnosis/surgery being 330 months/27.5 years with an average of 84.5 months/7 years (range: 1-660 months) (n = 57). Diagnosis was delayed in five cases, as the tumors were misdiagnosed for several years and even decades as either as benign adnexal tumors (syringoma 24 and cylindroma 35 ) or as BCCs. 37, 42, 48 PNI was found in 51 cases (55%) in which this parameter was available (n = 93) and local recurrences were seen in 33 (37%) of the 89 cases with follow-up information. Treatment strategies included local excision, wide local excision with or without radiotherapy with variable results. Micrographic surgery technique (Mohs) was performed in eight cases with excellent results. 18, 27, 31, 37, 40, 41, 48, 59 Multiple local recurrences were observed in six cases. Curiously, among the recurrent cases, an identical percentage of cases (36%) exhibited presence (16/45) and absence (8/22) of PNI, possibly suggesting occult foci of PNI in the cases deemed as negative. However, this assumption does not take in consideration the mode of treatment. The overall median time from last surgery to recurrence was also protracted: 45 months (mean: 59 months; range: 1-240). From the 84 cases in which this information was available, metastases were found in 15 cases (18%) with 10 cases showing visceral spread and 5 presenting only regional lymph node metastases 31, 35, 54, 65 (including our case 2). The majority of distant metastases were either seen solely affecting the lungs (six cases) 15, 32, 33, 63, 65 or lungs and brain (two cases), with the remainder two cases metastasizing to the liver and pericardium. Two cases with visceral metastases also shown preceding regional lymph node involvement and two cases showed spread first to lungs and then brain. The median time from diagnosis/surgery to the first metastasis was 60.5 months (mean: 85 months; range: 0-240). Most of the cases that developed metastases were related with local recurrences (12/14), recurrence information was not available in one metastatic case.
The results of this review, as well as the three cases reported herein, arranged in chronological order, are included in a table available in the  Table S1 , Supporting Information.
Discussion
Adnexal cutaneous neoplasms share some common entities with tumors derived from glandular organs found elsewhere in the body, most notoriously the salivary glands and the breast, which are basically 'modified sweat glands'. One of such tumors is the epithelial-myoepithelial malignancy known as ACC. This tumor very rarely arises in the skin, probably related to adnexal structures. Diagnosis of bona fide PCACC requires careful exclusion of both metastatic disease and/or contiguous cutaneous extension of an ACC arising from the breast, salivary glands or other possible non-cutaneous primary origin. This is a sine qua non requirement for PCACC diagnosis and forms part of the criteria laid by Seab & Graham in their PCACC series, 63 along with the following: tumors have to be dermal-based, show basaloid cells with at least cribriform growth pattern and be accompanied by mucin (glandular and/or stromal) and/or stromal hyalinization.
Although PCACC was first described as such by Boggio, 2 there were at least three examples already reported, but under different names, 3 -5 including the first documented description of this tumor back in 1951, authored by no other than Dr. AP Stout.
3 These three tumors were ultimately reclassified as PCACC in a subsequent publication by Cooper et al. 6 Our literature review yielded a total of 117 cases, including the three PCACC cases reported herein. After analyzing the data, we arrived to similar conclusions to the ones in the above-cited SEER-based study. 7 Thus, we confirmed that PCACC preferentially affects older individuals (median 60 years of age) and behaves as slow-growing, locally aggressive neoplasm with a tendency to show PNI, seen in 55% of cases, local recurrence, which presented in 35% of cases and a low, albeit considerable, metastatic potential (15% of cases metastasized). Interestingly, we found that both local recurrences and metastases often appeared many months, even decades, after the surgery, with a median of 45 and 60.5 months, respectively. Thus, long-term follow up is warranted and should be performed in these patients.
The other aim of this report was to contribute to the understanding of the molecular underpinnings of PCACC. Following the description of the t(6;9) (q22-23;p23-24) in salivary gland and breast ACCs by Dr. Stenman's group, 11 -13 this chromosomal aberration was found to be present in a ACCs arising form other gland-bearing organs elsewhere in the body. This translocation results in the production of a MYB-NFIB fusion, which is believed to be key in the generation of these neoplasms. The MYB proto-oncogene (6q22-q23) regulates, through its protein product the MYB transcription factor, normal hematopoiesis, neural development and colonic crypt homeostasis factor, 66 among other processes. MYB can be activated through overexpression or inappropriate expression, structural alteration in addition to genomic rearrangements next to an activating gene such as NFIB. 66 Altered MYB has been related in the oncogenesis of both acute and chronic myeloid leukemia as well as in T-cell acute lymphoblastic leukemia. This gene also appears amplified in esophagus, colon and breast carcinomas. 66 The NFIB gene (Nuclear Factor I/B, 9p24.1) codes the homonymous transcription factor, which is related to the FOXA1 transcription factor network and has been seen involved, apart from ACCs, in the genesis of pericolonic lipomas 67 and more recently as a prognostic factor in osteosarcomas (when present as a germline single nucleotide pleomorphism) 68 and giant cell tumors of bone. 69 The importance that MYB activation, either through gene alterations or MYB-NFIB fusions, has in ACC oncogenesis has been underscored by recent whole-exome sequencing studies 70, 71 of head and neck ACCs, which showed an otherwise 'quiet' mutational landscape with very few genetic aberrations. These findings indicate that activating MYB aberrations are probably driving these tumors. 14 A series of 21 PCACC (including to periocular ACCs) recently published by North et al. 14 describes the presence of MYB aberrations in a subset of 10 PCACC and 1 periocular ACC that were analyzed by MYB immunohistochemistry, FISH for MYB and Reverse Transcription Polymerase Chain Reaction (RT-PCR) for the MYB-NFIB fusion product. Immunohistochemistry for the MYB protein was positive in all but one of the PCACC (9/10) (the periocular ACC was not studied). Regarding the FISH results, they showed that six of the PCACC (including the periocular ACC case) showed either MYB splits (three PCACC and one periocular ACC) or deletion of the 3 ′ portion of the gene (two PCACC). Detection of the MYB-NFIB fusion product by RT-PCR was attempted in eight PCACC cases and in the periocular ACC case and showed that only two cases were positive, one PCACC and the periocular ACC, both of them also positive for a MYB splits on FISH. The case that was MYB-negative by immunohistochemistry was also negative for both MYB rearrangements by FISH and MYB-NFIB fusion transcript by RT-PCR and upon reexamination of the histopathology, the authors concluded that the lesion probably represents an ACC-like tumor, possibly a variant of a mixed tumor. Although FISH studies for NFIB were not carried out in this cohort, the RT-PCR data suggests that NFIB seems to be minimally involved in PCACC pathogenesis. As far as the MYB gene is concerned, it appears that a variety of aberrations play a role in its activation, including splits, loss of the 3 ′ portion and, judging by the widespread expression of MYB protein using immunohistochemistry, perhaps by a cryptic rearrangement that is not detected by conventional FISH, or through other mechanisms.
Our results replicate the findings by North et al. with the presence of balanced MYB splits in our first two cases, whereas a loss of 3 ′ (centromeric) portion with an accompanying copy number increase of MYB was found in the third case. As none of our cases showed NFIB abnormalities, MYB activation through MYB-NFIB fusion is unlikely. Results from both North et al. and our study are summarized in Table 1 .
As far as the potential diagnostic utility of MYB aberrations is concerned, the status of the MYB gene in the main entities included in the differential diagnosis of PCACC is not known. There is significant morphologic as well as immunohistochemical overlap between PCACC and three other cutaneous entities: BCC examples with extensive adenoid change 8 and the rare adnexal malignancies ACrC, 9 also known as primary cutaneous cribriform carcinoma (PCCC), 72 and PSGC. 10 Some subtle clues help in differentiating these tumors. While all of these tumors can potentially show some degree of cribriform architecture, the presence of infiltrating borders and, especially of PNI, in addition to the mucinous material and PAS-positive basement membrane material, would all favor PCACC over these entities. 8 -10,72 As far as the immunoprofile is concerned, PCACC is characterized by being CD117, S100 and Sox10 positive while being rimmed by p63-positive myoepithelial cells. 14 The absence of a S100/p63/Sox10 positive cell population will help in differentiating adenoid BCC from PCACC, while both PCACC and adenoid BCC will be positive with CD117. 14, 73 Similarly, while ACrC/PCCC and PSGC can show CD117 and S100 positivity, ACrC/PCCC will show no evidence of p63/Sox10 myoepithelial cells 9, 72 and PSGC will show a discontinuous rimming by such cells. 10 In addition to the above-described entities, some PCACC examples are known to show overlapping features with other basaloid adnexal tumors such as cylindromas and spiradenomas. 1 Interestingly, recent publications from Dr Stenman's group pointed out that a subset (8/12, 67%) of sporadic cutaneous cylindromas showed evidence of MYB-NFIB fusion and of MYB activation, detected either by FISH and/or RT-PCR of fusion transcripts as well as by MYB protein overexpression by immunohistochemistry. 74 In a follow-up paper, they have showed that cylindromas, mixed cylindromas/spiradenomas arising in individuals with germline CYLD mutations (Brooke-Spiegler syndrome) showed evidence of MYB activation, although not through the presence of MYB chromosomal aberrations or MYB-NFIB fusion, because these features were not seen in any of the tumors they studied. 75 It has been previously reported that Brooke-Spiegler syndrome patients also develop ACC-like BCCs of the salivary glands. 76 The presence of MYB aberrations have also been described in unrelated neoplasms such as in a small subset of prostatic basal cell adenomas that show ACC-like morphology. 77 These results suggest that MYB aberrations apparently play not only a pivotal role in oncogenesis of these lesions but also may contribute to the common histopathologic features among these different and seemingly unrelated tumors.
In summary, we can conclude that PCACC is a rare, low-grade malignant adnexal neoplasm with a low but significant metastatic risk. Approximately 61% of the studied cases appear to harbor MYB gene activations, either through MYB chromosomal abnormalities or, in a small fraction of cases, by generation of the MYB-NFIB fusion. When extrapolating data from ACC from other organs, this aberration appears to constitute the main genetic abnormality driving PCACCs.
